These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 139243)

  • 1. Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidin).
    Krook G
    Contact Dermatitis; 1975 Aug; 1(4):262. PubMed ID: 139243
    [No Abstract]   [Full Text] [Related]  

  • 2. Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidine).
    Krook G
    Contact Dermatitis; 1975 Dec; 1(6):385-6. PubMed ID: 139265
    [No Abstract]   [Full Text] [Related]  

  • 3. Contact sensitivity to oxyphenbutazone.
    Valsecchi R; Serra M; Foiadelli L; Cainelli T
    Contact Dermatitis; 1981 May; 7(3):157. PubMed ID: 7273732
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug reaction from oxyphenbutazone.
    Valsecchi R; Tornaghi A; Falgheri G; Rossi A; Cainelli T
    Contact Dermatitis; 1983 Sep; 9(5):419. PubMed ID: 6226482
    [No Abstract]   [Full Text] [Related]  

  • 5. Contact sensitivity to phenylbutazone (Butazolidine) cream.
    Nayar M; Ng SK
    Contact Dermatitis; 1991 Oct; 25(4):263-4. PubMed ID: 1839274
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of dermatitis medicamentosa].
    Kashchenko VB; Kozhukhar' GS
    Vrach Delo; 1986 Mar; (3):93-4. PubMed ID: 2940751
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary fibrositis and its treatment with the pyrazolone derivatives, butazolidin and tandearil.
    Klinefelter HF
    Johns Hopkins Med J; 1972 May; 130(5):300-7. PubMed ID: 4259693
    [No Abstract]   [Full Text] [Related]  

  • 8. [Contact allergy after phenylbutazone ointment. 4 cases and a review].
    Kaaber K; Thormann J
    Ugeskr Laeger; 1976 Jul; 138(29):1776-7. PubMed ID: 133486
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vasculitis allergica cutis caused by phenylbutazone].
    Paschoud JM
    Dermatologica; 1966; 133(1):76-86. PubMed ID: 4224583
    [No Abstract]   [Full Text] [Related]  

  • 10. Allergic contact dermatitis from oxyphenbutazone.
    Pigatto PD; Riboldi A; Morelli M; Altomare GF; Polenghi MM
    Contact Dermatitis; 1985 Apr; 12(4):236-7. PubMed ID: 3160537
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological evidence of two forms of allergy to pyrazolone drugs.
    Littlejohns DW; Assem ES; Kennedy CT
    Rheumatol Rehabil; 1973 May; 12(2):57-61. PubMed ID: 4126302
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medicinal treatment of arthroses. Effects of oxyphenbutazone (Tanderil) compared with phenylbutazone (Butazolidin)].
    GJORUP L
    Ugeskr Laeger; 1963 Jun; 125():863-5. PubMed ID: 13948319
    [No Abstract]   [Full Text] [Related]  

  • 13. Generalized pustular psoriasis precipitated by phenylbutazone and oxyphenbutazone.
    Reshad H; Hargreaves GK; Vickers CF
    Br J Dermatol; 1983 Jul; 109(1):111-3. PubMed ID: 6860567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.
    Inman WH
    Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed drug eruption to oxyphenbutazone and phenylbutazone.
    Nayyar KC; Pasricha JS
    Dermatologica; 1972; 144(4):214-6. PubMed ID: 5076722
    [No Abstract]   [Full Text] [Related]  

  • 16. Withdrawal of oxyphenbutazone: what about phenylbutazone?
    Biron P
    CMAJ; 1986 May; 134(10):1119-20. PubMed ID: 3697857
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Fixed skin eruption caused by oxyphenbutazone with cross-reactivity to phenylbutazone.
    Pandhi RK; Dedi TR
    Arch Dermatol; 1975 Jan; 111(1):131. PubMed ID: 1119818
    [No Abstract]   [Full Text] [Related]  

  • 18. [ACTION OF TANDERIL (OXYPHENBUTAZONE) AND BUTAZOLIDIN (PHENYLBUTAZONE) ON ALLERGIC INFLAMMATION].
    YAMASAKI H; SAIKAWA H; MASADA A
    Arerugi; 1964 Mar; 13():100-7. PubMed ID: 14138410
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic hazards of phenylbutazone and oxyphenbutazone in polymyalgia rheumatica.
    Wadman B; Werner I
    Lancet; 1967 Mar; 1(7490):597-8. PubMed ID: 4163976
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenylbutazone, oxyphenbutazone labeling revised.
    FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.